Tag Archives: structural heart disease

Introduction In the first article, we discussed those anomalies that are usually encountered by chance at, or just prior to, implantation; patent foramen ovale/atrial septal defect, Ebstein’s anomaly and ventricular septal defect, and the potential problems that they may provide to the device implanter. In the second article, we discussed the challenge of device implantation in patients with more complex congenital structural cardiac defects, which the operator should be aware of prior to device implantation, including congenitally corrected L-transposition of great arteries, tetralogy of Fallot and tricuspid atresia/univentricular heart. I

Introduction In the previous article, we discussed those anomalies that are usually encountered by chance at, or just prior to, implantation: patent foramen ovale/atrial septal defect, Ebstein’s anomaly and ventricular septal defect, and the potential problems that they may provide to the device implanter. In this and the next article, we will discuss the challenge of device implantation in patients with more complex congenital structural cardiac defects, which the operator should be aware of prior to device implantation. In this paper we include congenitally corrected L-transposition of great arteries (L-TGA), tetralogy of Fallot and tricu

Introduction The vast majority of patients requiring pacemaker or defibrillator implantation have structurally normal hearts and patients with congenital cardiac abnormalities constitute only a small proportion. The latter can be divided into two groups. The first includes those with undiscovered congenital abnormalities, which do not give rise to symptoms or obvious physical signs, such as dextrocardia, persistent left-sided superior vena cava, atrial septal defect and patent foramen ovale. The second group includes those who are known to have structural cardiac abnormalities, such as Ebstein’s anomaly, ventricular septal defect, transposi